Online group therapy shows promise for easing depression in cystic fibrosis patients
NCT ID NCT06645782
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an online group therapy program designed for adults with cystic fibrosis (CF) to help reduce depression, anxiety, and stress. Twenty-one participants completed questionnaires before and after the 8-week program, and some shared their experiences in interviews. The goal was to see if the virtual group format was practical and helpful for improving mental health and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
21 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * At least 18 years of age. * Must speak and read in English. * Must have depression and/or anxiety scores in the mild to moderate range (as per the PHQ-9 and GAD-7) prior to study baseline. Exclusion Criteria: * Those with suicidal intent (either with or without a plan).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cystic fibrosis (CF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Jubilee Hospital
Victoria, British Columbia, Canada
-
St. Paul Hospital
Vancouver, British Columbia, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glucose sensor may flag diabetes risk in cystic fibrosis
- Can Drug-Level testing personalize cystic fibrosis treatment?
- MRI could reveal a new way to ease gut troubles in cystic fibrosis
- AI may predict lung decline in cystic fibrosis kids using muscle and balance data
- Breathing vs. beating: which technique clears lungs better in cystic fibrosis?
- Could modern CF drugs make daily inhaled treatments obsolete?